Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nasser Altorki

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Cell Reports Methods|May 14, 2026
Tumor immune microenvironment reconstitution in patient-derived organoids enables therapy modeling for NSCLCEnrique Podaza, Jared Capuano, Hui-Hsuan Kuo, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
JAK1/2 Inhibition Delays Cachexia and Improves Survival through Increased Food IntakeEzequiel Dantas, Anirudh Murthy, Jeshua Kim, et al.
Science Translational Medicine|March 16, 2022
Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancerErik Wennerberg, Sumit Mukherjee, Sheila Spada, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 12, 2024
Initial patient characteristics of Thoracic Surgical Oncology Group 102: A multicenter prospective registry of active surveillance in patients with multiple ground-glass opacitiesJames Huang, Kay See Tan, Nasser Altorki, et al.
The Lancet. Oncology|May 2, 2016
Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trialJohan F Vansteenkiste, Byoung Chul Cho, Tonu Vanakesa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 13, 2023
International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant TherapySanja Dacic, William Travis, Mary Redman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 2, 2026
Machine learning assessment of pathologic response in lung cancer resections after neoadjuvant therapy - IASLC MPR ProjectSanja Dacic, Daniel Shenker, Mary Redman, et al.
Science Advances|June 26, 2026
Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilitiesHui-Hsuan Kuo, Bhavneet Bhinder, Hamza N Gokozan, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Cell Reports Methods|May 14, 2026
Tumor immune microenvironment reconstitution in patient-derived organoids enables therapy modeling for NSCLCEnrique Podaza, Jared Capuano, Hui-Hsuan Kuo, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
JAK1/2 Inhibition Delays Cachexia and Improves Survival through Increased Food IntakeEzequiel Dantas, Anirudh Murthy, Jeshua Kim, et al.
Science Translational Medicine|March 16, 2022
Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancerErik Wennerberg, Sumit Mukherjee, Sheila Spada, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 12, 2024
Initial patient characteristics of Thoracic Surgical Oncology Group 102: A multicenter prospective registry of active surveillance in patients with multiple ground-glass opacitiesJames Huang, Kay See Tan, Nasser Altorki, et al.
The Lancet. Oncology|May 2, 2016
Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trialJohan F Vansteenkiste, Byoung Chul Cho, Tonu Vanakesa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 13, 2023
International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant TherapySanja Dacic, William Travis, Mary Redman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 2, 2026
Machine learning assessment of pathologic response in lung cancer resections after neoadjuvant therapy - IASLC MPR ProjectSanja Dacic, Daniel Shenker, Mary Redman, et al.
Science Advances|June 26, 2026
Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilitiesHui-Hsuan Kuo, Bhavneet Bhinder, Hamza N Gokozan, et al.
Pageof 10